Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 48 Gastrointestinal Stromal Tumors 26 Leukemia 20 Leukemia, Myeloid, Chronic-Phase 15 Philadelphia Chromosome 9 Leukemia, Myeloid 8 Bone Marrow Diseases 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasms 4 Hematologic Neoplasms 4 Hematologic Diseases 4 Blast Crisis 4 Myeloproliferative Disorders 3 Leukemia, Myeloid, Acute 3 Hypereosinophilic Syndrome 3 Glioblastoma 3 Digestive System Neoplasms 3 Bronchiolitis Obliterans Syndrome 3 Recurrence 2 Prostatic Neoplasms 2 Neurofibrosarcoma 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Leukemia, Myeloid, Accelerated Phase 2 Dermatofibrosarcoma 2 Chordoma 2 Brain Neoplasms 2 Adenocarcinoma 2 Urogenital Neoplasms 1

Interventions

vactosertib 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Dermoid Cyst × Imatinib Mesylate × Clear all

NCT06219733 2024-12-09

MP-VAC-206

MedPacto, Inc.

Phase 2 Withdrawn

Dermoid Cyst

Data powered by HemOnc (CC BY 4.0) Colophon ⚡